Because EZH2 was documented to physically interacts and cooperate with E2F1 to stimulate the expression of a group of genes involved in cancer progression [15,22], we thus tested by co-immunoprecipitation whether such an interaction occurs in four different PAH-PASMC cell lines. The gene discussed is E2F1; the disease is cancer.